In cell line experiments, radiotherapy and temozolomide chemotherapy‐induced high expression of PD‐L1 in IDH‐mutant glioma cells with ATRX mutations, promoting tumor immune escape [20]. Here, IDH1 is linked to central nervous system cancer.